Skip to main content
. 2021 Dec 16;2:735819. doi: 10.3389/fresc.2021.735819

Table 1.

Participant demographics and clinical characteristics.

Participant Sex Age Stroke Lesion Time post MAS FM Pre/Post Nth Physical
(Years) type location stroke (Years) finger/wrist injection injection therapy
BTX 1 F 48 Isch R MCA-UD 4.6 3/3 23/26 6 Prescribed
BTX 2 M 58 Hem L Ip-BG 4.4 2/2 26/27 13 Prescribed
BTX 3 F 42 Hem L Ip-BG 3.9 3/4 19/22 12 Prescribed
BTX 4 M 77 Isch L MCA-LD, UD, Le 1.4 3/3 20/22 2 Prescribed
BTX 5 F 67 Isch R MCA-LD, UD 1.8 3/2 9/9 N/A N/A
BTX 6 F 60 Isch R MCA-LD, UD, Le 11.9 1/1 23/25 40 Prescribed
BTX 7 M 69 Isch L Pons 1.1 2/1 63/63 2 Not Prescribed
BTX 8 F 48 Isch R MCA-LD, UD 8.9 4/4 44/47 27 Home Exercises
BTX 9 M 55 Isch R MCA-LD, UD, Le 5.1 4/2 35/40 17 Home Exercises

MCA, middle cerebral artery; LD, Lower Division; UD, Upper Division; Le, Lenticulostriate; Ip, Intraparenchymal; BG, Basal Ganglia; R, Right; L, Left; Isch, Ischemic; Hem, Hemorrhagic; Note: information regarding the number of injections and details of physical therapy for participant number 5 was not available due to transfer between centers.